Aquatic Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Aquatic Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-21,195	Closed	-$487K	–	1373
2025 Q2	$487K	Buy	+21,195	New	+$526K	0.01%	829
2025 Q1	–	Sell	-7,036	Closed	-$261K	–	1243
2024 Q4	$261K	Buy	+7,036	New	+$322K	0.01%	872
2023 Q4	–	Sell	-4,100	Closed	-$189K	–	1301
2023 Q3	$189K	Buy	+4,100	New	+$224K	0.01%	684
2023 Q2	–	Sell	-5,700	Closed	-$214K	–	1304
2023 Q1	$214K	Buy	+5,700	New	+$187K	0.01%	570

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Aquatic Capital Management's AMPH Position: Q3 2025 in Review

Aquatic Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2025, closing a stake of 21,195 shares — an estimated $487K sold.

Aquatic Capital Management first reported a position in AMPH in Q1 2023 and held it in 4 quarters. The position peaked at $487K in Q2 2025. 243 funds tracked by Wall St. Rank hold AMPH as of Q3 2025.

Aquatic Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Aquatic Capital Management sold 21,195 Amphastar Pharmaceuticals shares in Q3 2025, an estimated $487K.
Aquatic Capital Management first reported a position in Amphastar Pharmaceuticals in Q1 2023 and held it in 4 quarters.
Aquatic Capital Management's Amphastar Pharmaceuticals position peaked at $487K in Q2 2025.
243 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2025.

Based on Aquatic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.